Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-12-29 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: COURS (69470), Rhone
SELARL PHARMACIE DE LA PLACE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA PLACE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in COURS (69470),
this company of category PME
shows in 2023 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA PLACE (SIREN 519121909)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 034 356 €
N/C
N/C
N/C
N/C
1 564 625 €
1 528 651 €
Net income
91 503 €
50 597 €
122 976 €
233 441 €
120 207 €
108 267 €
108 842 €
112 581 €
131 038 €
EBITDA
N/C
N/C
172 354 €
N/C
N/C
N/C
N/C
172 324 €
209 680 €
Net margin
N/C
N/C
6.0%
N/C
N/C
N/C
N/C
7.2%
8.6%
Revenue and income statement
In 2025, SELARL PHARMACIE DE LA PLACE generates positive net income of 92 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 131 k€ -> 92 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
91 503 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
24.198%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.276%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE LA PLACE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
88.603
62.822
49.846
37.108
30.119
21.491
23.006
27.309
24.198
Financial autonomy
49.067
56.455
61.531
67.608
68.449
74.034
74.572
71.361
74.276
Repayment capacity
5.313
4.868
None
None
None
None
2.768
None
None
Cash flow / Revenue
8.348%
7.117%
None%
None%
None%
None%
6.061%
None%
None%
Sector positioning
Debt ratio
24.22025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good+6 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE DE LA PLACE (24.20) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
74.28%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent
In 2025, the financial autonomy of SELARL PHARMACIE DE LA PLACE (74.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
2.77 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of SELARL PHARMACIE DE LA PLACE (2.77) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 485.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
485.8
Liquidity indicators evolution SELARL PHARMACIE DE LA PLACE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
361.181
311.79
354.788
388.431
294.898
383.737
508.861
448.149
485.8
Interest coverage
9.322
9.517
None
None
None
None
4.567
None
None
Sector positioning
Liquidity ratio
485.82025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of SELARL PHARMACIE DE LA PLACE (485.80) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
4.57x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of SELARL PHARMACIE DE LA PLACE (4.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE LA PLACE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
143 510 €
158 919 €
0 €
0 €
0 €
0 €
181 098 €
0 €
0 €
Inventory turnover (days)
32
29
0
0
0
0
30
0
0
Customer payment term (days)
5
5
0
0
0
0
4
0
0
Supplier payment term (days)
27
32
0
0
0
0
22
0
0
Positioning of SELARL PHARMACIE DE LA PLACE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DE LA PLACE is estimated at
1 453 536 €
(range 986 376€ - 2 280 798€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
986k€1453k€2280k€
1 453 536 €Range: 986 376€ - 2 280 798€
NAF 5 année 2025
Valuation method used
Net Income Multiple
91 503 €
×
15.9x
=1 453 536 €
Range: 986 376€ - 2 280 798€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE LA PLACE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA PLACE
What is the revenue of SELARL PHARMACIE DE LA PLACE ?
The revenue of SELARL PHARMACIE DE LA PLACE in 2023 is 2.0 M€.
Is SELARL PHARMACIE DE LA PLACE profitable?
Yes, SELARL PHARMACIE DE LA PLACE generated a net profit of 92 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DE LA PLACE ?
The headquarters of SELARL PHARMACIE DE LA PLACE is located in COURS (69470), in the department Rhone.
Where to find the tax return of SELARL PHARMACIE DE LA PLACE ?
The tax return of SELARL PHARMACIE DE LA PLACE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA PLACE operate?
SELARL PHARMACIE DE LA PLACE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart